Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
DISCO Pharmaceuticals GmbH logo — The surfaceome company.

DISCO Pharmaceuticals GmbH

The surfaceome company.

Founded 2022 Germany Cologne, Germany 25 employees Seed Total: $20.00M Health and Wellness, Manufacturing +1

General Information

Company Name DISCO Pharmaceuticals GmbH
Founded Year 2022
Location Germany Cologne, Germany +1
Employees 25
Industries Health and Wellness, Manufacturing, Pharmaceutical
Funding Stage Seed
Social

Get notified when DISCO Pharmaceuticals GmbH moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About DISCO Pharmaceuticals GmbH

DISCO Pharmaceuticals GmbH, with the slogan "The surfaceome company," is a 2022-founded enterprise based in Germany. The company offers a pioneering surfaceome mapping platform that revolutionizes target discovery for large molecule R&D. This technology, backed by a recent €20.00M Seed Round investment at 16 January 2024 from Sofinnova Partners, AbbVie Ventures, MERL Ventures Fund, and Panakes Partners, identifies proteins and protein communities across the entire cancer cell surface at scale. This innovative approach addresses the critical need for target candidates for both mono- and bi-specific antibodies, laying the groundwork for the development of a myriad of cancer-selective therapies. These insights have the potential to significantly enhance efficacy and reduce side effects for patients. With its focus on the Manufacturing and Pharmaceutical industries, DISCO Pharmaceuticals GmbH is poised to make substantial contributions to the field of cancer research and treatment, positioning itself as a promising investment opportunity.

Taxonomy: target discovery, large molecule R&D, cancer cell surface mapping, protein identification, cancer-selective therapies, bi-specific antibodies, effective cancer treatments

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 4
Investor Investor Investor Investor
16 Jan 2024

DISCO Pharmaceuticals GmbH Alternatives & Competitors

DISCO Pharmaceuticals GmbH vs
Vaxon Biotech
Vaxon Biotech

Therapeutic vaccines empowering your immune system to target cancer without harming healthy cells, f...

3 employees
Biotechnology, Health Care
DISCO Pharmaceuticals GmbH vs
StemSynergy Therapeutics, Inc.
StemSynergy Therapeutics, Inc. United States

Stem Cell Research Drives Innovative Cancer Therapeutics

6 employees
Biotechnology
Compare DISCO Pharmaceuticals GmbH vs StemSynergy Therapeutics, Inc.
DISCO Pharmaceuticals GmbH vs
Novelogics Biotechnology Inc.
Novelogics Biotechnology Inc. Canada

Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer using an “In...

Angel
1 employees
Biotechnology, Health Care
Compare DISCO Pharmaceuticals GmbH vs Novelogics Biotechnology Inc.
Also compare with: DISCO Pharmaceuticals GmbH vs Tradewind BioScience Tradewind BioScience

FAQ About DISCO Pharmaceuticals GmbH

The surfaceome company.
DISCO Pharmaceuticals GmbH was founded in 2022.
DISCO Pharmaceuticals GmbH is headquartered in Cologne, Germany.
DISCO Pharmaceuticals GmbH operates in the following industries: Health and Wellness, Manufacturing, Pharmaceutical.
DISCO Pharmaceuticals GmbH has approximately 25 employees.
DISCO Pharmaceuticals GmbH has completed 1 funding round, raising a total of $20.00M. The latest funding stage is Seed.
Top alternatives and competitors to DISCO Pharmaceuticals GmbH include Vaxon Biotech, StemSynergy Therapeutics, Inc., Novelogics Biotechnology Inc., Tradewind BioScience, Crossbow Therapeutics, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DISCO Pharmaceuticals GmbH and Vaxon Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors DISCO Pharmaceuticals GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes